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background: Timing, causality, and outcomes of permanent pacemaker (PPM) following transcatheter aortic valve replacement (TAVR) remains 
poorly described.
Methods: Symptomatic aortic stenosis patients undergoing TVAR were followed for timing and underlying causes of PPM implantation. They were 
categorized into 3 groups according to those with no PPM (NoPPM), prior PPM (PrePPM), and PPM post-procedure (PostPPM) and the outcomes 
were compared. The primary end point was mortality at 1 year. Secondary end points included major stroke, worsening heart failure class, and 
hospital length of stay.
results: A total of 450 consecutive patients underwent TAVR. The median implantation time was 4 days (range: 1-17) with the most common 
underlying cause being complete AV block (58%). Baseline characteristics in NoPPM (n=347), PrePPM (n=78) and PostPPM (n=25) groups reveled 
the highest prevalence of Afib in the PostPPM group compared with PrePPM and NoPPM patients (56% vs. 28% and 33%; p=0.03). PostPPM patients 
had a trend towards higher early mortality compared to NoPPM and PrePM (landmark p=0.09); however, no difference in mortality was found at 1 
year (p=0.63). (Table)
conclusion: The most frequent PPM cause is complete AV block. Although not associated with 1-year mortality, the clinical complications were 
higher in patients who required PPM compared to those who did not. Efforts to minimize conduction disturbances in TAVR patients are warranted.











33 (9.5) 5 (6.4) 4 (16) 0.46
Mortality
1 year, (%)
77 (22) 19 (24) 12 (48) 0.91
Major stroke, (%) 11 (3.2) 3 (3.9) 3 (12) 0.08
Worsening heart failure class, (%) 57 (17) 19 (25) 12 (48) <0.01
Hospital lenght of stay, (%) 9.1± 6.8 9.1 ± 6.8 12.8 ± 9.6 <0.05
